FIELD: medicine.
SUBSTANCE: given invention refers to medicine and concerns a combination for treating an oncological disease, containing as an active ingredient, at least one immunostimulating drug of general formula and one or more chemotherapeutic agents chosen from the group consisting of alkylating agents including carboplatin, cisplatin and oxaliplatin, cytostatic agents chosen from cyclophosphamide and its derivatives, and antimetabolites chosen from fluorouracila and its derivatives, and to a method of treating oncological conditions.
EFFECT: invention provides higher clinical effectiveness.
18 cl, 8 dwg, 5 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED APPLICATION OF EPA, DPA AND DHA WITH CHEMOTHERAPEUTIC AGENT | 2012 |
|
RU2637406C2 |
COMBINED DRUG FOR TREATMENT OF TUMOR DISEASES | 2002 |
|
RU2291710C2 |
COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID | 2011 |
|
RU2605335C2 |
COMBINATION THERAPY WITH ANTICANCER ALKALOID | 2018 |
|
RU2767664C2 |
COMBINATION THERAPY WITH ANTITUMOR ALKALOID | 2011 |
|
RU2743643C2 |
COMBINATION THERAPY WITH ANTITUMOR ALKALOID | 2018 |
|
RU2757373C2 |
IMPROVED METHODS FOR TREATING TUMOURS | 2007 |
|
RU2481853C2 |
ABX196 FOR USE IN TREATMENT OF BLADDER CANCER | 2018 |
|
RU2778812C2 |
METHOD OF TREATING CANCER (VERSIONS) | 2006 |
|
RU2447889C2 |
PHARMACEUTICAL COMPOSITION, COMPOSITION OF STANDARD MEDICINAL FORM AND METHOD OF TREATMENT OF MALIGNANT NEOPLASM, TUMOR AND VIRAL INFECTION | 1996 |
|
RU2197964C2 |
Authors
Dates
2010-08-20—Published
2005-03-10—Filed